SIMILAR PATTERN OF AMINO ACIDS MAPPED TO 'SSA'
DrReposER ID / Desc. | Hit PDBID |
Hit Macromolecule |
Res. Matches |
Interface | HETATM | RMSD | Dali Z-score |
Seq. Identity (%) |
View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1DMI_A_BHSA1610_1 (NITRIC OXIDESYNTHASE) |
3hxw | ALANYL-TRNASYNTHETASE (Escherichiacoli) | 4 / 8 | ALA A 138TRP A 142PHE A 215GLU A 183 | NoneNoneNoneSSA A 442 ( 4.7A) | 1.08A | 1dmiA-3hxwA:undetectable1dmiB-3hxwA:undetectable | 1dmiA-3hxwA:23.091dmiB-3hxwA:23.09 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1NYR_A_THRA1004_0 (THREONYL-TRNASYNTHETASE 1) |
4eo4 | THREONINE--TRNALIGASE,MITOCHONDRIAL (Saccharomycescerevisiae) | 8 / 10 | MET A 131CYH A 133ARG A 162ASP A 182HIS A 184TYR A 270GLN A 292HIS A 319 | SSA A1001 (-3.8A) ZN A1003 (-2.9A)SSA A1001 (-2.8A)SSA A1001 (-2.8A) ZN A1003 (-3.6A)NoneSSA A1001 (-3.3A) ZN A1003 ( 3.5A) | 0.34A | 1nyrA-4eo4A:47.7 | 1nyrA-4eo4A:27.87 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1NYR_B_THRB2004_0 (THREONYL-TRNASYNTHETASE 1) |
4eo4 | THREONINE--TRNALIGASE,MITOCHONDRIAL (Saccharomycescerevisiae) | 8 / 10 | MET A 131CYH A 133ARG A 162ASP A 182HIS A 184TYR A 270GLN A 292HIS A 319 | SSA A1001 (-3.8A) ZN A1003 (-2.9A)SSA A1001 (-2.8A)SSA A1001 (-2.8A) ZN A1003 (-3.6A)NoneSSA A1001 (-3.3A) ZN A1003 ( 3.5A) | 0.78A | 1nyrB-4eo4A:45.5 | 1nyrB-4eo4A:27.87 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1ONI_F_BEZF511_0 (14.5 KDATRANSLATIONALINHIBITOR PROTEIN) |
3w3s | TYPE-2 SERINE--TRNALIGASE (Methanopyruskandleri) | 4 / 5 | TYR A 323GLU A 368PHE A 409ALA A 317 | NoneSSA A2002 ( 2.5A) PT A2004 (-0.7A)SSA A2002 (-4.4A) | 1.40A | 1oniE-3w3sA:0.01oniF-3w3sA:0.0 | 1oniE-3w3sA:12.291oniF-3w3sA:12.29 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1TW4_A_CHDA130_1 (FATTY ACID-BINDINGPROTEIN) |
4eo4 | THREONINE--TRNALIGASE,MITOCHONDRIAL (Saccharomycescerevisiae) | 3 / 3 | TYR A 95ARG A 162GLN A 180 | NoneSSA A1001 (-2.8A)SSA A1001 (-3.4A) | 0.94A | 1tw4A-4eo4A:undetectable | 1tw4A-4eo4A:14.63 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2COJ_A_GBNA420_1 (BRANCHED CHAINAMINOTRANSFERASE 1,CYTOSOLIC) |
4eo4 | THREONINE--TRNALIGASE,MITOCHONDRIAL (Saccharomycescerevisiae) | 5 / 11 | TYR A 109ARG A 162TYR A 270GLY A 267ALA A 268 | NoneSSA A1001 (-2.8A)NoneNoneNone | 1.20A | 2cojA-4eo4A:undetectable2cojB-4eo4A:undetectable | 2cojA-4eo4A:20.782cojB-4eo4A:20.78 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2FN1_A_SALA506_1 (SALICYLATESYNTHETASE, IRP9) |
3hxw | ALANYL-TRNASYNTHETASE (Escherichiacoli) | 5 / 11 | ILE A 243GLY A 94THR A 236LEU A 114GLY A 239 | NoneNoneNoneNoneSSA A 442 (-3.5A) | 1.28A | 2fn1A-3hxwA:undetectable | 2fn1A-3hxwA:22.61 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3LOQ_A_ACTA278_0 (UNIVERSAL STRESSPROTEIN) |
3w3s | TYPE-2 SERINE--TRNALIGASE (Methanopyruskandleri) | 3 / 3 | SER A 449GLY A 451SER A 405 | SSA A2002 (-3.1A)SSA A2002 (-3.4A)None | 0.56A | 3loqA-3w3sA:undetectable | 3loqA-3w3sA:20.04 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4K87_A_ADNA602_1 (PROLINE--TRNA LIGASE) |
3w3s | TYPE-2 SERINE--TRNALIGASE (Methanopyruskandleri) | 5 / 8 | ARG A 349ARG A 360PHE A 364GLY A 451ARG A 485 | SSA A2002 (-3.0A)NoneSSA A2002 ( 3.5A)SSA A2002 (-3.4A)SSA A2002 ( 3.7A) | 1.14A | 4k87A-3w3sA:22.6 | 4k87A-3w3sA:21.66 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4K87_A_ADNA602_1 (PROLINE--TRNA LIGASE) |
4eo4 | THREONINE--TRNALIGASE,MITOCHONDRIAL (Saccharomycescerevisiae) | 5 / 8 | ARG A 162PHE A 178GLN A 287THR A 290ARG A 328 | SSA A1001 (-2.8A)SSA A1001 (-3.8A)SSA A1001 (-3.6A)SSA A1001 ( 4.3A)SSA A1001 (-3.7A) | 0.50A | 4k87A-4eo4A:26.5 | 4k87A-4eo4A:25.32 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4KR4_C_AICC401_1 (OUTER MEMBRANEPROTEIN F) |
2dq3 | SERYL-TRNASYNTHETASE (Aquifexaeolicus) | 4 / 8 | ARG A 262ASP A 336GLU A 119ARG A 391 | SSA A1001 (-2.8A)NoneNoneSSA A1001 (-3.3A) | 1.41A | 4kr4C-2dq3A:undetectable | 4kr4C-2dq3A:22.25 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4M6T_A_SAMA201_0 (RNA POLYMERASEII-ASSOCIATED FACTOR1 HOMOLOG, LINKER,RNAPOLYMERASE-ASSOCIATED PROTEIN LEO1) |
3w3s | TYPE-2 SERINE--TRNALIGASE (Methanopyruskandleri) | 4 / 4 | ILE A 367VAL A 450VAL A 483ARG A 229 | NoneSSA A2002 (-4.8A)NoneNone | 0.96A | 4m6tA-3w3sA:undetectable | 4m6tA-3w3sA:15.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4Q15_B_HFGB803_0 (PROLINE--TRNA LIGASE) |
2dq3 | SERYL-TRNASYNTHETASE (Aquifexaeolicus) | 5 / 12 | GLU A 264ARG A 262GLU A 233SER A 354GLY A 384 | SSA A1001 (-3.3A)SSA A1001 (-2.8A)SSA A1001 (-3.7A)NoneSSA A1001 (-3.7A) | 1.02A | 4q15B-2dq3A:22.8 | 4q15B-2dq3A:22.43 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4WNW_B_RTZB602_1 (CYTOCHROME P450 2D6) |
3w3s | TYPE-2 SERINE--TRNALIGASE (Methanopyruskandleri) | 5 / 12 | PHE A 242GLY A 451ALA A 388VAL A 402VAL A 455 | NoneSSA A2002 (-3.4A)NoneNoneNone | 1.13A | 4wnwB-3w3sA:undetectable | 4wnwB-3w3sA:22.87 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4XZK_A_AG2A700_1 (PUTATIVENAD(+)--ARGININEADP-RIBOSYLTRANSFERASE VIS) |
3w3s | TYPE-2 SERINE--TRNALIGASE (Methanopyruskandleri) | 4 / 7 | SER A 405ARG A 485SER A 449GLU A 430 | NoneSSA A2002 ( 3.7A)SSA A2002 (-3.1A)None | 1.41A | 4xzkA-3w3sA:undetectable | 4xzkA-3w3sA:18.32 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4YDQ_A_HFGA802_0 (PROLINE--TRNA LIGASE) |
2dq3 | SERYL-TRNASYNTHETASE (Aquifexaeolicus) | 5 / 12 | GLU A 264ARG A 262GLU A 233SER A 354GLY A 384 | SSA A1001 (-3.3A)SSA A1001 (-2.8A)SSA A1001 (-3.7A)NoneSSA A1001 (-3.7A) | 1.00A | 4ydqA-2dq3A:22.6 | 4ydqA-2dq3A:22.59 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4YDQ_B_HFGB802_0 (PROLINE--TRNA LIGASE) |
2dq3 | SERYL-TRNASYNTHETASE (Aquifexaeolicus) | 5 / 12 | GLU A 264ARG A 262GLU A 233SER A 354GLY A 384 | SSA A1001 (-3.3A)SSA A1001 (-2.8A)SSA A1001 (-3.7A)NoneSSA A1001 (-3.7A) | 1.04A | 4ydqB-2dq3A:22.3 | 4ydqB-2dq3A:22.59 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5B2Q_A_ACTA1728_0 (CRISPR-ASSOCIATEDENDONUCLEASE CAS9) |
3w3s | TYPE-2 SERINE--TRNALIGASE (Methanopyruskandleri) | 3 / 3 | ASN A 454SER A 452ARG A 366 | SSA A2002 (-4.3A)SSA A2002 (-2.9A)SSA A2002 (-3.0A) | 0.77A | 5b2qA-3w3sA:undetectable | 5b2qA-3w3sA:14.55 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5F9Z_B_HFGB703_0 (AMINOACYL-TRNASYNTHETASE) |
2dq3 | SERYL-TRNASYNTHETASE (Aquifexaeolicus) | 5 / 12 | GLU A 264ARG A 262GLU A 233SER A 354GLY A 384 | SSA A1001 (-3.3A)SSA A1001 (-2.8A)SSA A1001 (-3.7A)NoneSSA A1001 (-3.7A) | 1.04A | 5f9zB-2dq3A:22.4 | 5f9zB-2dq3A:21.72 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5IGJ_A_CTYA402_1 (MACROLIDE2'-PHOSPHOTRANSFERASE) |
2dq3 | SERYL-TRNASYNTHETASE (Aquifexaeolicus) | 5 / 12 | ILE A 276ASP A 336VAL A 339ALA A 306GLY A 384 | NoneNoneNoneNoneSSA A1001 (-3.7A) | 1.07A | 5igjA-2dq3A:0.1 | 5igjA-2dq3A:20.74 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5MXB_A_ML1A222_1 (CLASS 10 PLANTPATHOGENESIS-RELATEDPROTEIN) |
4eo4 | THREONINE--TRNALIGASE,MITOCHONDRIAL (Saccharomycescerevisiae) | 5 / 10 | VAL A 278LEU A 333PHE A 211GLY A 324ALA A 289 | NoneNoneNoneSSA A1001 (-3.3A)None | 1.15A | 5mxbA-4eo4A:1.1 | 5mxbA-4eo4A:11.82 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5X7Z_A_BHAA201_0 (UNCHARACTERIZEDHTH-TYPETRANSCRIPTIONALREGULATOR RV2887) |
3w3s | TYPE-2 SERINE--TRNALIGASE (Methanopyruskandleri) | 4 / 6 | LEU A 435VAL A 433LEU A 398VAL A 450 | NoneNoneNoneSSA A2002 (-4.8A) | 0.75A | 5x7zA-3w3sA:0.9 | 5x7zA-3w3sA:14.29 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5XIO_A_HFGA801_0 (PROLINE-TRNASYNTHETASE CLASS IIAARS (YBAK RNABINDING DOMAIN PLUSTRNA SYNTHETASE)) |
2dq3 | SERYL-TRNASYNTHETASE (Aquifexaeolicus) | 5 / 12 | GLU A 264ARG A 262GLU A 233SER A 354GLY A 384 | SSA A1001 (-3.3A)SSA A1001 (-2.8A)SSA A1001 (-3.7A)NoneSSA A1001 (-3.7A) | 1.12A | 5xioA-2dq3A:11.6 | 5xioA-2dq3A:22.67 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5XIO_B_HFGB802_0 (PROLINE-TRNASYNTHETASE CLASS IIAARS (YBAK RNABINDING DOMAIN PLUSTRNA SYNTHETASE)) |
4eo4 | THREONINE--TRNALIGASE,MITOCHONDRIAL (Saccharomycescerevisiae) | 5 / 12 | GLU A 164PRO A 130ARG A 162HIS A 184THR A 290 | SSA A1001 (-4.1A)NoneSSA A1001 (-2.8A) ZN A1003 (-3.6A)SSA A1001 ( 4.3A) | 1.28A | 5xioB-4eo4A:26.9 | 5xioB-4eo4A:22.93 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5XIP_D_HFGD1003_0 (PROLYL-TRNASYNTHETASE, PUTATIVE) |
2dq3 | SERYL-TRNASYNTHETASE (Aquifexaeolicus) | 5 / 12 | LEU A 205PRO A 230THR A 231GLU A 233ARG A 262 | NoneNoneSSA A1001 (-3.2A)SSA A1001 (-3.7A)SSA A1001 (-2.8A) | 1.05A | 5xipD-2dq3A:22.0 | 5xipD-2dq3A:23.02 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5XIQ_B_HFGB1002_0 (PROLYL-TRNASYNTHETASE (PRORS)) |
4eo4 | THREONINE--TRNALIGASE,MITOCHONDRIAL (Saccharomycescerevisiae) | 5 / 12 | GLU A 164PRO A 130ARG A 162HIS A 184THR A 290 | SSA A1001 (-4.1A)NoneSSA A1001 (-2.8A) ZN A1003 (-3.6A)SSA A1001 ( 4.3A) | 1.34A | 5xiqB-4eo4A:26.8 | 5xiqB-4eo4A:20.42 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5Z6J_A_FOLA201_1 (DIHYDROFOLATEREDUCTASE) |
4eo4 | THREONINE--TRNALIGASE,MITOCHONDRIAL (Saccharomycescerevisiae) | 3 / 3 | MET A 277ASP A 266ARG A 162 | NoneNoneSSA A1001 (-2.8A) | 0.84A | 5z6jA-4eo4A:undetectable | 5z6jA-4eo4A:17.87 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5Z6K_A_FOLA201_1 (DIHYDROFOLATEREDUCTASE) |
4eo4 | THREONINE--TRNALIGASE,MITOCHONDRIAL (Saccharomycescerevisiae) | 3 / 3 | MET A 277ASP A 266ARG A 162 | NoneNoneSSA A1001 (-2.8A) | 0.78A | 5z6kA-4eo4A:undetectable | 5z6kA-4eo4A:17.87 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6BNI_A_ADNA602_1 (LYSINE--TRNA LIGASE) |
2dq3 | SERYL-TRNASYNTHETASE (Aquifexaeolicus) | 5 / 10 | ARG A 262GLU A 264PHE A 281GLU A 349ARG A 391 | SSA A1001 (-2.8A)SSA A1001 (-3.3A)SSA A1001 (-3.5A)SSA A1001 (-3.1A)SSA A1001 (-3.3A) | 0.68A | 6bniA-2dq3A:4.9 | 6bniA-2dq3A:9.41 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6BNI_A_ADNA602_1 (LYSINE--TRNA LIGASE) |
3hxw | ALANYL-TRNASYNTHETASE (Escherichiacoli) | 6 / 10 | ARG A 69HIS A 86PHE A 90GLU A 209GLY A 239ARG A 242 | SSA A 442 (-2.7A)NoneSSA A 442 (-3.5A)SSA A 442 (-3.9A)SSA A 442 (-3.5A)SSA A 442 (-3.8A) | 0.69A | 6bniA-3hxwA:13.4 | 6bniA-3hxwA:12.01 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6BNI_A_ADNA602_1 (LYSINE--TRNA LIGASE) |
3w3s | TYPE-2 SERINE--TRNALIGASE (Methanopyruskandleri) | 5 / 10 | ARG A 349GLU A 351PHE A 364GLY A 482ARG A 485 | SSA A2002 (-3.0A)SSA A2002 (-3.2A)SSA A2002 ( 3.5A)SSA A2002 (-2.8A)SSA A2002 ( 3.7A) | 0.84A | 6bniA-3w3sA:9.8 | 6bniA-3w3sA:9.30 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6BNI_A_ADNA602_1 (LYSINE--TRNA LIGASE) |
4eo4 | THREONINE--TRNALIGASE,MITOCHONDRIAL (Saccharomycescerevisiae) | 5 / 10 | ARG A 162GLU A 164PHE A 178GLY A 324ARG A 328 | SSA A1001 (-2.8A)SSA A1001 (-4.1A)SSA A1001 (-3.8A)SSA A1001 (-3.3A)SSA A1001 (-3.7A) | 0.69A | 6bniA-4eo4A:11.4 | 6bniA-4eo4A:11.52 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6BNI_A_ADNA602_1 (LYSINE--TRNA LIGASE) |
4l87 | SERINE--TRNA LIGASE,CYTOPLASMIC (Homosapiens) | 5 / 10 | ARG A 302GLU A 304PHE A 321GLU A 391ARG A 435 | SSA A 501 (-2.4A)SSA A 501 (-3.4A)SSA A 501 (-3.5A) MG A 503 (-3.3A)SSA A 501 (-4.0A) | 0.89A | 6bniA-4l87A:10.3 | 6bniA-4l87A:10.86 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6BNI_B_ADNB602_1 (LYSINE--TRNA LIGASE) |
2dq3 | SERYL-TRNASYNTHETASE (Aquifexaeolicus) | 5 / 10 | ARG A 262GLU A 264PHE A 281GLU A 349ARG A 391 | SSA A1001 (-2.8A)SSA A1001 (-3.3A)SSA A1001 (-3.5A)SSA A1001 (-3.1A)SSA A1001 (-3.3A) | 0.66A | 6bniB-2dq3A:12.4 | 6bniB-2dq3A:9.41 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6BNI_B_ADNB602_1 (LYSINE--TRNA LIGASE) |
3hxw | ALANYL-TRNASYNTHETASE (Escherichiacoli) | 6 / 10 | ARG A 69HIS A 86PHE A 90GLU A 209GLY A 239ARG A 242 | SSA A 442 (-2.7A)NoneSSA A 442 (-3.5A)SSA A 442 (-3.9A)SSA A 442 (-3.5A)SSA A 442 (-3.8A) | 0.69A | 6bniB-3hxwA:12.0 | 6bniB-3hxwA:12.01 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6BNI_B_ADNB602_1 (LYSINE--TRNA LIGASE) |
3w3s | TYPE-2 SERINE--TRNALIGASE (Methanopyruskandleri) | 5 / 10 | ARG A 349GLU A 351PHE A 364GLY A 482ARG A 485 | SSA A2002 (-3.0A)SSA A2002 (-3.2A)SSA A2002 ( 3.5A)SSA A2002 (-2.8A)SSA A2002 ( 3.7A) | 0.84A | 6bniB-3w3sA:10.6 | 6bniB-3w3sA:9.30 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6BNI_B_ADNB602_1 (LYSINE--TRNA LIGASE) |
4eo4 | THREONINE--TRNALIGASE,MITOCHONDRIAL (Saccharomycescerevisiae) | 5 / 10 | ARG A 162GLU A 164PHE A 178GLY A 324ARG A 328 | SSA A1001 (-2.8A)SSA A1001 (-4.1A)SSA A1001 (-3.8A)SSA A1001 (-3.3A)SSA A1001 (-3.7A) | 0.67A | 6bniB-4eo4A:12.8 | 6bniB-4eo4A:11.52 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6BNI_B_ADNB602_1 (LYSINE--TRNA LIGASE) |
4l87 | SERINE--TRNA LIGASE,CYTOPLASMIC (Homosapiens) | 5 / 10 | ARG A 302GLU A 304PHE A 321GLU A 391ARG A 435 | SSA A 501 (-2.4A)SSA A 501 (-3.4A)SSA A 501 (-3.5A) MG A 503 (-3.3A)SSA A 501 (-4.0A) | 0.92A | 6bniB-4l87A:12.0 | 6bniB-4l87A:10.86 |